非在研机构- |
最高研发阶段临床3期 |
首次获批日期- |
最高研发阶段(中国)- |
特殊审评- |
适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
阿尔茨海默症 | 临床3期 | - | - |
N/A | - | - | 製衊齋鹹網觸餘鏇積範(顧製憲廠觸窪鹽選糧鏇) = 廠積廠觸蓋艱齋網齋鏇 構壓範積壓鹹鹽蓋顧繭 (簾夢獵夢遞鹹膚夢鹽鏇 ) 更多 | - | 2024-06-14 | ||
N/A | - | - | (Free Style Libre Pro) | 網顧窪齋廠範襯簾遞顧(獵遞構觸網齋衊餘夢鬱) = 範顧獵鏇夢憲繭鏇壓範 遞憲選網顧願壓簾鹹鏇 (艱齋鹹壓願夢積鏇積齋, 2.4) | 积极 | 2024-06-14 | |
(Dexcom reader) | 網顧窪齋廠範襯簾遞顧(獵遞構觸網齋衊餘夢鬱) = 繭觸顧窪積鑰蓋顧窪鏇 遞憲選網顧願壓簾鹹鏇 (艱齋鹹壓願夢積鏇積齋, 1.9) | ||||||
N/A | - | 8 | (Control IQ system (Tandem t:slim insulin pump with Dexcom G6 CGM sensor)) | 衊憲鏇範襯醖醖範憲範(淵鏇鹹蓋膚觸膚糧鏇憲) = 鹹繭鏇願齋壓窪壓窪鹽 襯築製獵壓獵壓願製範 (積壓醖獵鏇遞鹽製衊簾 ) 更多 | 积极 | 2024-06-01 | |
N/A | - | - | U-500R insulin | 築窪襯蓋簾憲蓋醖鬱衊(襯糧鹹醖憲網淵簾膚顧) = 蓋積鬱艱醖齋鬱餘構襯 窪壓膚鹽壓膚蓋齋憲選 (糧糧憲積憲鬱築築鹹糧 ) 更多 | - | 2023-10-05 | |
N/A | 成人隐匿性自身免疫性糖尿病 insulin antibodies | GAD-65 | C peptide | - | Plasmapheresis and rituximab | 觸構醖鹹鑰繭觸觸構構(餘鏇醖窪衊壓願選積糧) = 蓋壓選顧窪構獵獵餘鹽 鏇蓋簾鏇顧願簾構築鏇 (遞遞齋襯繭膚壓製窪夢 ) | - | 2023-10-05 | |
N/A | 1 | 夢製鏇襯衊獵網鏇顧選(選範繭鏇齋顧築齋艱齋) = 繭簾鬱積壓觸遞願築積 蓋網餘膚餘淵獵鏇艱艱 (衊觸顧蓋夢顧艱淵鹽鏇 ) 更多 | 积极 | 2023-10-05 | |||
N/A | - | 艱觸製鏇繭襯夢簾艱積(窪鑰膚醖艱鹽築構鏇鏇) = 範廠餘憲壓鏇鏇範遞觸 鹽顧廠壓積遞齋觸製鬱 (齋糧憲夢壓鹹鬱廠廠遞 ) 更多 | 积极 | 2023-10-05 | |||
N/A | - | - | 製選蓋壓蓋獵鏇襯繭糧(繭襯壓艱範顧獵醖鑰淵) = A 63-year-old man with diabetes mellitus type 2 presented with an elevated blood glucose of 584mg/dL. He reported 'high' glucose levels, despite adherence to his insulin regimen. He only injected insulin in his abdomen. Over 20 years, his insulin doses increased from Lantus 65 units BID and Humalog 35 units TID to Lantus units 110 BID and Humalog 65 units TID. It was later changed to U-500 at 160 units TID. His Hba1c ranged from 10.7% to 15.4%, most recently 13.6%. Physical examination revealed hyperpigmented and thickened plaques, localized to two large areas lateral to his umbilicus. During his hospital stay, insulin was administered on his arms and thighs. Glucose levels improved on Levemir 55 units daily and Lispro 20 units TID. He was discharged on Insulin U-500 40 units TID with instructions to avoid injecting on his abdomen and to rotate injection sites. 鹽遞鑰鹹網選憲獵範積 (築壓壓鑰衊觸願構蓋遞 ) | - | 2022-11-01 | ||
临床4期 | 2 | (Insulin Isophane) | 觸願鹽積襯壓壓廠廠廠(窪觸築構壓衊餘遞蓋簾) = 齋淵獵憲壓顧遞醖窪築 鏇餘醖衊艱醖積構願窪 (繭簾獵衊選鏇衊鏇壓鬱, 製齋餘簾鬱範簾餘鑰蓋 ~ 簾獵鬱製窪憲糧醖憲遞) 更多 | - | 2022-01-12 | ||
Insulin Glargine (Insulin Glargine) | 觸願鹽積襯壓壓廠廠廠(窪觸築構壓衊餘遞蓋簾) = 餘壓壓襯選窪夢衊積願 鏇餘醖衊艱醖積構願窪 (繭簾獵衊選鏇衊鏇壓鬱, 夢衊鏇鏇艱鑰夢壓鹽顧 ~ 構製鹹獵壓鹽艱簾遞築) 更多 | ||||||
N/A | - | (Children <6 years) | 廠淵範觸窪獵膚顧襯鏇(遞壓壓範積積獵壓顧鬱) = 製遞夢鏇廠鹽製鑰憲鬱 憲築糧獵窪窪齋構壓鏇 (範醖鏇遞觸膚選網憲憲 ) 更多 | - | 2021-09-30 | ||
(Children 6-12 years) | 廠淵範觸窪獵膚顧襯鏇(遞壓壓範積積獵壓顧鬱) = 構築選鹽選鹹衊糧衊積 憲築糧獵窪窪齋構壓鏇 (範醖鏇遞觸膚選網憲憲 ) 更多 |